-
1
-
-
0018552079
-
Treatment of plasma cell myeloma
-
Bergsagel, D. E. Treatment of plasma cell myeloma. Ann. Rev. Med., 30: 431-433, 1979.
-
(1979)
Ann. Rev. Med.
, vol.30
, pp. 431-433
-
-
Bergsagel, D.E.1
-
2
-
-
0024552490
-
Reassessment of the relationship between M-protein decrement and survival in multiple myeloma
-
Palmer, M., Belch, A., Hanson, J., and Brox, L. Reassessment of the relationship between M-protein decrement and survival in multiple myeloma. Br. J. Cancer, 59: 110-112, 1989.
-
(1989)
Br. J. Cancer
, vol.59
, pp. 110-112
-
-
Palmer, M.1
Belch, A.2
Hanson, J.3
Brox, L.4
-
3
-
-
8944220233
-
A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma
-
Attal, M., Harosseau, J-L., Stoppa, A-M., Sotto, J-J., Fuzibet, J-G., Rossi, J-F., Cassasus, P., Maisonneuve, H., Facon, T., Ifrah, N., Payen, C., and Batialle, R. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N. Engl. J. Med., 335: 91-97, 1996.
-
(1996)
N. Engl. J. Med.
, vol.335
, pp. 91-97
-
-
Attal, M.1
Harosseau, J.-L.2
Stoppa, A.-M.3
Sotto, J.-J.4
Fuzibet, J.-G.5
Rossi, J.-F.6
Cassasus, P.7
Maisonneuve, H.8
Facon, T.9
Ifrah, N.10
Payen, C.11
Batialle, R.12
-
4
-
-
0343309958
-
Circulating, monoclonal, multi-drug resistant B cells may comprise the malignant stem cells population in multiple myeloma
-
F. Dammaco and B. Barlogie (eds.)
-
Pilarski, L. M., Mant, M. J., and Belch, A. R. Circulating, monoclonal, multi-drug resistant B cells may comprise the malignant stem cells population in multiple myeloma. In: F. Dammaco and B. Barlogie (eds.), Challenges in Modern Medicine, Vol. 4, pp. 31-39, 1994.
-
(1994)
Challenges in Modern Medicine
, vol.4
, pp. 31-39
-
-
Pilarski, L.M.1
Mant, M.J.2
Belch, A.R.3
-
5
-
-
0025820771
-
Selective expression of CD45 isoforms defines CALLA+ monoclonal B lineage cells in peripheral blood from myeloma patients as late stage B cells
-
Jensen, G. S., Mant, M. J., Belch, A. R., Berensen, J. R., Ruether, B. A., and Pilarski, L. M. Selective expression of CD45 isoforms defines CALLA+ monoclonal B lineage cells in peripheral blood from myeloma patients as late stage B cells. Blood, 78: 711-719, 1991.
-
(1991)
Blood
, vol.78
, pp. 711-719
-
-
Jensen, G.S.1
Mant, M.J.2
Belch, A.R.3
Berensen, J.R.4
Ruether, B.A.5
Pilarski, L.M.6
-
6
-
-
0026552179
-
Monoclonal circulating B cells in multiple myeloma: A continuously differentiating possibly invasive population as defined by expression of CD45 isoforms and adhesion molecules
-
Pilarski, L. M., and Jensen, G. S. Monoclonal circulating B cells in multiple myeloma: a continuously differentiating possibly invasive population as defined by expression of CD45 isoforms and adhesion molecules. Hematol. Oncol. Clin. N. Am., 6: 297-322, 1992.
-
(1992)
Hematol. Oncol. Clin. N. Am.
, vol.6
, pp. 297-322
-
-
Pilarski, L.M.1
Jensen, G.S.2
-
7
-
-
0031036891
-
CD34+ cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient-specific IgH VDJ rearrangements
-
Szczepek, A. J., Bergsagel, P. L., Axelsson, L., Brown, C. B., Belch, A. R., and Pilarski, L. M. CD34+ cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient-specific IgH VDJ rearrangements. Blood, 89: 1824-1833, 1997.
-
(1997)
Blood
, vol.89
, pp. 1824-1833
-
-
Szczepek, A.J.1
Bergsagel, P.L.2
Axelsson, L.3
Brown, C.B.4
Belch, A.R.5
Pilarski, L.M.6
-
8
-
-
0030736702
-
Deficient drug transporter function of bone marrow-localized and leukemic plasma cells in multiple myeloma
-
Pilarski, L. M., Szczepek, A. J., and Belch, A. R. Deficient drug transporter function of bone marrow-localized and leukemic plasma cells in multiple myeloma. Blood, 90: 3751-3759, 1997.
-
(1997)
Blood
, vol.90
, pp. 3751-3759
-
-
Pilarski, L.M.1
Szczepek, A.J.2
Belch, A.R.3
-
9
-
-
0030045099
-
Hyaluronan-dependent motility of B cells and leukemic plasma cells but not of bone marrow plasma cells in multiple myeloma: Alternate usage of RHAMM and CD44
-
Masellis-Smith, A., Belch, A. R., Mant, M. J., Turley, E. A., and Pilarski, L. M. Hyaluronan-dependent motility of B cells and leukemic plasma cells but not of bone marrow plasma cells in multiple myeloma: alternate usage of RHAMM and CD44. Blood, 87: 1891-1899, 1996.
-
(1996)
Blood
, vol.87
, pp. 1891-1899
-
-
Masellis-Smith, A.1
Belch, A.R.2
Mant, M.J.3
Turley, E.A.4
Pilarski, L.M.5
-
10
-
-
0032531999
-
A high frequency of circulating B cells share clonotypic IgH VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single cell and in situ RT-PCR
-
Szczepek, A. J., Seeberger, K., Wizniak, J., Mant, M. J., Belch, A. R., and Pilarski, L. M. A high frequency of circulating B cells share clonotypic IgH VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single cell and in situ RT-PCR. Blood, 92: 2844-2855, 1998.
-
(1998)
Blood
, vol.92
, pp. 2844-2855
-
-
Szczepek, A.J.1
Seeberger, K.2
Wizniak, J.3
Mant, M.J.4
Belch, A.R.5
Pilarski, L.M.6
-
11
-
-
0028908877
-
In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic immunoglobulin light chain
-
Bergsagel, P. L., Masellis, S., Szczepek, A., Mant, M. J., Belch, A. R., and Pilarski, L. M. In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic immunoglobulin light chain. Blood, 85: 436-447, 1995.
-
(1995)
Blood
, vol.85
, pp. 436-447
-
-
Bergsagel, P.L.1
Masellis, S.2
Szczepek, A.3
Mant, M.J.4
Belch, A.R.5
Pilarski, L.M.6
-
12
-
-
0018721299
-
Studies on the clonal origin of multiple myeloma
-
Kubagawa, H., Vogler, L. B., Capra, J. D., Conrad, M. E., Lawton, A. R., and Cooper, M. D. Studies on the clonal origin of multiple myeloma. J. Exp. Med., 150: 792-807, 1979.
-
(1979)
J. Exp. Med.
, vol.150
, pp. 792-807
-
-
Kubagawa, H.1
Vogler, L.B.2
Capra, J.D.3
Conrad, M.E.4
Lawton, A.R.5
Cooper, M.D.6
-
13
-
-
24544466082
-
Evidence that myeloma may originate from an antigen-driven clone that persists after malignant transformation: Pre-switch B cells in the circulation of myeloma patients exhibit mutational diversity in the variable region of clonal IgM and IgD transcripts
-
Szczepek, A. J., Belch, A. R., and Pilarski, L. M. Evidence that myeloma may originate from an antigen-driven clone that persists after malignant transformation: pre-switch B cells in the circulation of myeloma patients exhibit mutational diversity in the variable region of clonal IgM and IgD transcripts. Blood, 92: 257a-257a, 1998.
-
(1998)
Blood
, vol.92
-
-
Szczepek, A.J.1
Belch, A.R.2
Pilarski, L.M.3
-
14
-
-
0028246112
-
Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell
-
Bakkus, M. H. C., Van Riet, I., Van Camp, B., and Thielemann, K. Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell. Br. J. Haematol., 87: 68-74, 1994.
-
(1994)
Br. J. Haematol.
, vol.87
, pp. 68-74
-
-
Bakkus, M.H.C.1
Van Riet, I.2
Van Camp, B.3
Thielemann, K.4
-
15
-
-
0027257608
-
The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell
-
Billadeau, D., Ahmann, G., Greipp, P., and Van Ness, B. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J. Exp. Med., 178: 1023-1031, 1993.
-
(1993)
J. Exp. Med.
, vol.178
, pp. 1023-1031
-
-
Billadeau, D.1
Ahmann, G.2
Greipp, P.3
Van Ness, B.4
-
16
-
-
0027296754
-
Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to c-mu sequence in immunoglobulin (IgG) and IgA secreting multiple myelomas
-
Corradini, P., Boccadoro, M., Voena, C., and Pilieri, A. Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to c-mu sequence in immunoglobulin (IgG) and IgA secreting multiple myelomas. J. Exp. Med., 178; 1091-1096, 1993.
-
(1993)
J. Exp. Med.
, vol.178
, pp. 1091-1096
-
-
Corradini, P.1
Boccadoro, M.2
Voena, C.3
Pilieri, A.4
-
17
-
-
0016192364
-
Monoclonal lymphocytes in human plasma cell myeloma
-
Mellstedt, H., Hammarstrom, S., and Holm, G. Monoclonal lymphocytes in human plasma cell myeloma. Clin. Exp. Immunol., 17: 371-384, 1974.
-
(1974)
Clin. Exp. Immunol.
, vol.17
, pp. 371-384
-
-
Mellstedt, H.1
Hammarstrom, S.2
Holm, G.3
-
18
-
-
0024389383
-
Tumor cell heterogeneity in multiple myeloma: Antigenic, morphologic, and functional studies of cells from blood and bone marrow
-
King, M. A., and Nelsonm, D. S. Tumor cell heterogeneity in multiple myeloma: antigenic, morphologic, and functional studies of cells from blood and bone marrow. Blood, 73: 1925-1935, 1989.
-
(1989)
Blood
, vol.73
, pp. 1925-1935
-
-
King, M.A.1
Nelsonm, D.S.2
-
19
-
-
0024243657
-
Phenotypical and functional characterization of the idiotype-positive blood B cells in multiple myeloma
-
Bloem, A. C., Chand, M. A., van Camp, B., Bast, E. J., and Ballieux, R. E. Phenotypical and functional characterization of the idiotype-positive blood B cells in multiple myeloma. Scand. J. Immunol., 28: 791-799, 1988.
-
(1988)
Scand. J. Immunol.
, vol.28
, pp. 791-799
-
-
Bloem, A.C.1
Chand, M.A.2
Van Camp, B.3
Bast, E.J.4
Ballieux, R.E.5
-
20
-
-
0020093141
-
Idiotype-bearing lymphoid cells in plasma cell neoplasia
-
Mellstedt, H., Holm, G., Pettersson, D., and Peest, D. Idiotype-bearing lymphoid cells in plasma cell neoplasia. Clin. Haematol., 11: 65-86, 1982.
-
(1982)
Clin. Haematol.
, vol.11
, pp. 65-86
-
-
Mellstedt, H.1
Holm, G.2
Pettersson, D.3
Peest, D.4
-
21
-
-
0025838831
-
Establishment of idiotype bearing B-lymphocyte clones from a patient with monoclonal gammopathy
-
Osterborg, A., Steinitz, M., Lewin, N., Bergenbrant, S., Holm, G., Lefvert, A. K., and Mellstedt, H. Establishment of idiotype bearing B-lymphocyte clones from a patient with monoclonal gammopathy. Blood, 78: 2642-2649, 1991.
-
(1991)
Blood
, vol.78
, pp. 2642-2649
-
-
Osterborg, A.1
Steinitz, M.2
Lewin, N.3
Bergenbrant, S.4
Holm, G.5
Lefvert, A.K.6
Mellstedt, H.7
-
22
-
-
0018956010
-
Monoclonal B lymphocytes in multiple myeloma
-
Pettersson, D., Mellstedt, H., and Holm, G. Monoclonal B lymphocytes in multiple myeloma. Scand. J. Immunol., 12: 375-382, 1980.
-
(1980)
Scand. J. Immunol.
, vol.12
, pp. 375-382
-
-
Pettersson, D.1
Mellstedt, H.2
Holm, G.3
-
23
-
-
0026687227
-
Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients
-
Billadeau, D., Quam, L., Thomas, W., Kay, N. E., Greipp, P., Kyle, R., Oken, M. M., and Van Ness, B. Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood, 80: 1818-1824, 1992.
-
(1992)
Blood
, vol.80
, pp. 1818-1824
-
-
Billadeau, D.1
Quam, L.2
Thomas, W.3
Kay, N.E.4
Greipp, P.5
Kyle, R.6
Oken, M.M.7
Van Ness, B.8
-
24
-
-
0029957126
-
Clonal circulating cells are common in plasma cell proliferative disorders: A comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma
-
Billadeau, D., Van Ness, B., Kimlinger, T., Kyle, R. A., Therneau, T. M., Greipp, P. R., and Witzig, T. E. Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma. Blood, 88: 289-296, 1996.
-
(1996)
Blood
, vol.88
, pp. 289-296
-
-
Billadeau, D.1
Van Ness, B.2
Kimlinger, T.3
Kyle, R.A.4
Therneau, T.M.5
Greipp, P.R.6
Witzig, T.E.7
-
25
-
-
0029015660
-
Idiotypic oligonucleotide probes to detect myeloma cells by mRNA in situ hybridization
-
Brown, R., Luo, X. F., Gibson, J., Morley, A., Sykes, P., Brisco, M., and Joshua, D. Idiotypic oligonucleotide probes to detect myeloma cells by mRNA in situ hybridization. Br. J. Haematol., 90: 113-118, 1998.
-
(1998)
Br. J. Haematol.
, vol.90
, pp. 113-118
-
-
Brown, R.1
Luo, X.F.2
Gibson, J.3
Morley, A.4
Sykes, P.5
Brisco, M.6
Joshua, D.7
-
26
-
-
0030049654
-
Circulating clonal lymphocytes in myeloma constitute a minor population of B cells
-
Chen, B. J., and Epstein, J. Circulating clonal lymphocytes in myeloma constitute a minor population of B cells. Blood, 87: 1972-1976, 1996.
-
(1996)
Blood
, vol.87
, pp. 1972-1976
-
-
Chen, B.J.1
Epstein, J.2
-
27
-
-
84929564445
-
Myeloma progenitors in the blood of patients with aggressive or minimal disease: Engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice
-
in press
-
Pilarski, L. M., Hipperson, G., Seeberger, K., Pruski, E., Coupland, R. W., and Belch, A. R. Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice. Blood, in press, 1999.
-
(1999)
Blood
-
-
Pilarski, L.M.1
Hipperson, G.2
Seeberger, K.3
Pruski, E.4
Coupland, R.W.5
Belch, A.R.6
-
28
-
-
0029946705
-
Tumor-specific aneuploidy not detected in CD19+ B lymphoid cells from myeloma patients in a multidimensional flow cytometry analysis
-
McSweeney, P. A., Wells, D. A., Shults, K. E., Nash, R. A., Bensinger, W. I., Buckner, C. D., and Loken, M. R. Tumor-specific aneuploidy not detected in CD19+ B lymphoid cells from myeloma patients in a multidimensional flow cytometry analysis. Blood, 88: 622-632, 1996.
-
(1996)
Blood
, vol.88
, pp. 622-632
-
-
McSweeney, P.A.1
Wells, D.A.2
Shults, K.E.3
Nash, R.A.4
Bensinger, W.I.5
Buckner, C.D.6
Loken, M.R.7
-
29
-
-
0018899398
-
Cellular DNA content as a marker of human multiple myeloma
-
Latreille, J., Barlogie, B. A., Dosik, G. A., Johnson, D. A., Drewinko, B., and Alexanian, R. Cellular DNA content as a marker of human multiple myeloma. Blood, 55: 81-90; 403-408, 1980.
-
(1980)
Blood
, vol.55
, pp. 81-90
-
-
Latreille, J.1
Barlogie, B.A.2
Dosik, G.A.3
Johnson, D.A.4
Drewinko, B.5
Alexanian, R.6
-
30
-
-
0021335916
-
Plasma cell DNA content in multiple myeloma and related paraproteinemic disorders. Relationship with clinical and cytokinetic features
-
Montecucco, C., Riccardi, A., Merlini, G., Mazzini, G., Giordano, P., Danova, M., and Ascari, E. Plasma cell DNA content in multiple myeloma and related paraproteinemic disorders. Relationship with clinical and cytokinetic features. Br. J. Cancer Clin. Oncol., 20: 81-90, 1984.
-
(1984)
Br. J. Cancer Clin. Oncol.
, vol.20
, pp. 81-90
-
-
Montecucco, C.1
Riccardi, A.2
Merlini, G.3
Mazzini, G.4
Giordano, P.5
Danova, M.6
Ascari, E.7
-
31
-
-
0024551187
-
Detection of hypodiploidy using multiparameter flow cytometric analysis: A prognostic indicator in multiple myeloma
-
Morgan, R. J., Jr., Gonchoroff, N. J., Katzmann, J. A., Witzig, T. E., Kyle, R. A., and Greipp, P. R. Detection of hypodiploidy using multiparameter flow cytometric analysis: a prognostic indicator in multiple myeloma. Am. J. Hematol., 30: 195-200, 1989.
-
(1989)
Am. J. Hematol.
, vol.30
, pp. 195-200
-
-
Morgan R.J., Jr.1
Gonchoroff, N.J.2
Katzmann, J.A.3
Witzig, T.E.4
Kyle, R.A.5
Greipp, P.R.6
-
32
-
-
0026572260
-
Flow cytometric DNA analysis and clinical correlations in multiple myeloma
-
Tienhaara, A., and Pelliniemi, T. T. Flow cytometric DNA analysis and clinical correlations in multiple myeloma. Am. J. Clin. Pathol., 97: 322-330, 1992.
-
(1992)
Am. J. Clin. Pathol.
, vol.97
, pp. 322-330
-
-
Tienhaara, A.1
Pelliniemi, T.T.2
-
33
-
-
0023759258
-
Correlated flow cytometric analysis of Ha-ras p21 and nuclear DNA in multiple myeloma
-
Tsuchiya, H., Welhamepstein, J., Selvanayagam, P., Dedman, J. R., Gallick, G., Alexanian, R., and Barlogie, B. Correlated flow cytometric analysis of Ha-ras p21 and nuclear DNA in multiple myeloma. Blood, 72: 796-800, 1988.
-
(1988)
Blood
, vol.72
, pp. 796-800
-
-
Tsuchiya, H.1
Welhamepstein, J.2
Selvanayagam, P.3
Dedman, J.R.4
Gallick, G.5
Alexanian, R.6
Barlogie, B.7
-
34
-
-
0025969581
-
DNA and RNA flow cytometric study in multiple myeloma
-
Tafuri, A., Meyers, J., Lee, B. J., and Andreeff, M. DNA and RNA flow cytometric study in multiple myeloma. Cancer (Phila.), 67: 449-454: 1991.
-
(1991)
Cancer (Phila.)
, vol.67
, pp. 449-454
-
-
Tafuri, A.1
Meyers, J.2
Lee, B.J.3
Andreeff, M.4
-
35
-
-
0026522839
-
Immunophenotype, and DNA content of myeloma cells in primary plasma cell leukemia
-
Shimazaki, C., Gotoh, H., Ashihara, E., Oku, N., Inaba, T., Murakami, S., Itoh, K., Ura, Y., Nakagawa, M., and Fujita, N. Immunophenotype, and DNA content of myeloma cells in primary plasma cell leukemia. Am. J. Hematol., 39: 159-162, 1992.
-
(1992)
Am. J. Hematol.
, vol.39
, pp. 159-162
-
-
Shimazaki, C.1
Gotoh, H.2
Ashihara, E.3
Oku, N.4
Inaba, T.5
Murakami, S.6
Itoh, K.7
Ura, Y.8
Nakagawa, M.9
Fujita, N.10
-
36
-
-
0028289637
-
Image analysis in multiple myeloma at diagnosis. Correlation with cytogenetic study
-
Zandecki, M., Bernardi, F., Lai, J. L., Facon, T., Izydorczyk, V., Bauters, F., and Cosson, A. Image analysis in multiple myeloma at diagnosis. Correlation with cytogenetic study. Cancer Genet. Cytogenet., 74: 115-119, 1994.
-
(1994)
Cancer Genet. Cytogenet.
, vol.74
, pp. 115-119
-
-
Zandecki, M.1
Bernardi, F.2
Lai, J.L.3
Facon, T.4
Izydorczyk, V.5
Bauters, F.6
Cosson, A.7
-
37
-
-
0029070777
-
Prognostic implications of DNA aneuploidy in 156 untreated multiple myeloma patients
-
Garcia-Sanz, R., Orfao, A., Gonzalez, M., Moro, M. J., Hernandez, J. M., Ortega, F., Borrego, D., Carnero, M., Casanova, F., Jimenez, R., Portero, J. A., and San Miguel, J. F. Prognostic implications of DNA aneuploidy in 156 untreated multiple myeloma patients. Br. J. Haematol., 90: 106-112, 1995.
-
(1995)
Br. J. Haematol.
, vol.90
, pp. 106-112
-
-
Garcia-Sanz, R.1
Orfao, A.2
Gonzalez, M.3
Moro, M.J.4
Hernandez, J.M.5
Ortega, F.6
Borrego, D.7
Carnero, M.8
Casanova, F.9
Jimenez, R.10
Portero, J.A.11
San Miguel, J.F.12
-
38
-
-
0028947460
-
Improved cytogenetics in multiple myeloma: A study of 151 patients including 117 patients at diagnosis
-
Lai, J. L., Zandecki, M., Mary, J. Y., Bernardi, F., Izydorczyk, V., Flactif, M., Morel, P., Jouet, J. P., Bauters, F., and Facon, T. Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood, 85: 2490-2497, 1995.
-
(1995)
Blood
, vol.85
, pp. 2490-2497
-
-
Lai, J.L.1
Zandecki, M.2
Mary, J.Y.3
Bernardi, F.4
Izydorczyk, V.5
Flactif, M.6
Morel, P.7
Jouet, J.P.8
Bauters, F.9
Facon, T.10
-
39
-
-
0028168180
-
RHAMM, a receptor for hyaluronan-mediated motility, on normal lymphocytes, thymocytes and in B cell malignancy: A mediator in B cell malignancy?
-
Pilarski, L. M., Masellis Smith, A., Belch, A. R., Yang, B., Savani, R. C., and Turley, E. A. RHAMM, a receptor for hyaluronan-mediated motility, on normal lymphocytes, thymocytes and in B cell malignancy: a mediator in B cell malignancy? Leuk. Lymphoma, 14: 363-374, 1994.
-
(1994)
Leuk. Lymphoma
, vol.14
, pp. 363-374
-
-
Pilarski, L.M.1
Masellis Smith, A.2
Belch, A.R.3
Yang, B.4
Savani, R.C.5
Turley, E.A.6
-
40
-
-
0027976530
-
Circulating monoclonal B cells expressing p-glycoprotein may be a reservoir of multidrug resistant disease in multiple myeloma
-
Pilarski, L. M., and Belch, A. R. Circulating monoclonal B cells expressing p-glycoprotein may be a reservoir of multidrug resistant disease in multiple myeloma. Blood, 83: 724-736, 1994.
-
(1994)
Blood
, vol.83
, pp. 724-736
-
-
Pilarski, L.M.1
Belch, A.R.2
-
41
-
-
0019479971
-
Mithramycin and 4′-6′-diamidino-2-phenylindole (DAPI)-DNA staining for fluorescence microspectrophotometric measurement of DNA in nuclei, plastids, and virus particles
-
Coleman, A. W., Maguire, M. J., and Coleman, J. R. Mithramycin and 4′-6′-diamidino-2-phenylindole (DAPI)-DNA staining for fluorescence microspectrophotometric measurement of DNA in nuclei, plastids, and virus particles. J. Histochem. Cytochem., 29: 959-968, 1981.
-
(1981)
J. Histochem. Cytochem.
, vol.29
, pp. 959-968
-
-
Coleman, A.W.1
Maguire, M.J.2
Coleman, J.R.3
-
42
-
-
0025131482
-
Simultaneous measurement of DNA content and cell-surface immunofluorescence of human bone marrow cells using a single laser flow cytometer
-
Brons, P. P. T., Pennings, A. H. M., Haanen, C., Wessels, H. M. C., and Boezeman, J. B. M. Simultaneous measurement of DNA content and cell-surface immunofluorescence of human bone marrow cells using a single laser flow cytometer. Cytometry, 11: 837-844, 1990.
-
(1990)
Cytometry
, vol.11
, pp. 837-844
-
-
Brons, P.P.T.1
Pennings, A.H.M.2
Haanen, C.3
Wessels, H.M.C.4
Boezeman, J.B.M.5
-
43
-
-
0018076581
-
Biology of the human myeloma cell population. II. Cytokinetic characteristics
-
Hulin, N., Conte, P. F., and Pileri, A. Biology of the human myeloma cell population. II. Cytokinetic characteristics. Clin. Lab., 8: 49-55, 1978.
-
(1978)
Clin. Lab.
, vol.8
, pp. 49-55
-
-
Hulin, N.1
Conte, P.F.2
Pileri, A.3
-
44
-
-
0028882866
-
S-phase cells of the lymphoplasmocytic compartment in hyperdiploid multiple myeloma are diploid cells
-
Haraldsdottir, V., Haanen, C., Kalsbeek-Batenburg, E., and Olthuis, F. S-phase cells of the lymphoplasmocytic compartment in hyperdiploid multiple myeloma are diploid cells. Cytometry, 21: 203-210, 1995.
-
(1995)
Cytometry
, vol.21
, pp. 203-210
-
-
Haraldsdottir, V.1
Haanen, C.2
Kalsbeek-Batenburg, E.3
Olthuis, F.4
-
45
-
-
0029162938
-
Cytogenetic findings in 200 patients with multiple myeloma
-
Sawyer, J. R., Waldron, J. A., Jagannath, S., and Barlogie, B. Cytogenetic findings in 200 patients with multiple myeloma. Cancer Genet. Cytogenet., 83: 41-49, 1995.
-
(1995)
Cancer Genet. Cytogenet.
, vol.83
, pp. 41-49
-
-
Sawyer, J.R.1
Waldron, J.A.2
Jagannath, S.3
Barlogie, B.4
-
46
-
-
8944237001
-
Incidence of chromosome numerical changes in multiple myeloma Fluorescence in situ hybridization analysis using 15 chromosome-specific probes
-
Tabernero, D., San Miguel, J. F., Garcia-Sanz, R., Najera, L., Garcia-Isidoro, M., Perez-Simon, J. A., Raap, A. K., and Orfao, A. Incidence of chromosome numerical changes in multiple myeloma Fluorescence in situ hybridization analysis using 15 chromosome-specific probes. Am. J. Pathol., 149: 153-161, 1996.
-
(1996)
Am. J. Pathol.
, vol.149
, pp. 153-161
-
-
Tabernero, D.1
San Miguel, J.F.2
Garcia-Sanz, R.3
Najera, L.4
Garcia-Isidoro, M.5
Perez-Simon, J.A.6
Raap, A.K.7
Orfao, A.8
-
47
-
-
0030211192
-
Multiple myeloma: Almost all patients are cytogenetically abnormal
-
Zandecki, M., Lai, J. L., and Facon, T. Multiple myeloma: almost all patients are cytogenetically abnormal. Br. J. Haematol., 94: 217-227, 1996.
-
(1996)
Br. J. Haematol.
, vol.94
, pp. 217-227
-
-
Zandecki, M.1
Lai, J.L.2
Facon, T.3
-
48
-
-
0030790529
-
Involvement of peripheral blood cells in multiple myeloma: Chromosome changes are the rule within circulating plasma cells but not within B lymphocytes
-
Zandecki, M., Bernardi, F., Genevieve, F., Lai, J. L., Preudhomme, C., Flactif, M., Cosson, A., Bauters, F., and Facon, T. Involvement of peripheral blood cells in multiple myeloma: chromosome changes are the rule within circulating plasma cells but not within B lymphocytes. Leukemia, 11: 1034-1039, 1997.
-
(1997)
Leukemia
, vol.11
, pp. 1034-1039
-
-
Zandecki, M.1
Bernardi, F.2
Genevieve, F.3
Lai, J.L.4
Preudhomme, C.5
Flactif, M.6
Cosson, A.7
Bauters, F.8
Facon, T.9
-
49
-
-
0343309897
-
Cryptic expression of the CD19 epitope detected by mAb Leu12 distinguishes malignant from residual polyclonal B cells in the blood of myeloma patients
-
Pilarski, L. M., Szczepek, A. J., Mant, M. J., and Belch, A. R. Cryptic expression of the CD19 epitope detected by mAb Leu12 distinguishes malignant from residual polyclonal B cells in the blood of myeloma patients. Blood, 90: 349a-349a, 1997.
-
(1997)
Blood
, vol.90
-
-
Pilarski, L.M.1
Szczepek, A.J.2
Mant, M.J.3
Belch, A.R.4
-
50
-
-
0342440346
-
Single cell IgH cdr3 and in situ RT-PCR for IgH CDR3 and Ig light chain unequivocally confirm that circulating CD19+ cells in multiple myeloma are B cells
-
Pilarski, L. M., Szczepek, A., MacDonald, H., Mant, M. J., and Belch, A. R. Single cell IgH CDR3 and in situ RT-PCR for IgH CDR3 and Ig light chain unequivocally confirm that circulating CD19+ cells in multiple myeloma are B cells. Blood, 86: 58a, 1995.
-
(1995)
Blood
, vol.86
-
-
Pilarski, L.M.1
Szczepek, A.2
MacDonald, H.3
Mant, M.J.4
Belch, A.R.5
-
51
-
-
0033104710
-
Overexpression of the hyaluronan receptor RHAMM characterizes the malignant clone in multiple myeloma: Identification of three distinct RHAMM isoforms
-
Crainie, M., Mant, M. J., Belch, A. R., and Pilarski, L. M. Overexpression of the hyaluronan receptor RHAMM characterizes the malignant clone in multiple myeloma: identification of three distinct RHAMM isoforms. Blood, 93: 1684-1696, 1999.
-
(1999)
Blood
, vol.93
, pp. 1684-1696
-
-
Crainie, M.1
Mant, M.J.2
Belch, A.R.3
Pilarski, L.M.4
-
52
-
-
0030890414
-
Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma
-
Kimlinger, T., and Witzig, T. E. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma. Bone Marrow Transplant., 19: 553-556, 1997.
-
(1997)
Bone Marrow Transplant.
, vol.19
, pp. 553-556
-
-
Kimlinger, T.1
Witzig, T.E.2
-
53
-
-
0027971582
-
The hematopoietic stem cell antigen CD34 is not expressed on the malignant cells in multiple myeloma
-
Vescio, R. A., Hong, C. H., Cao, J., Kim, A., Schiller, G. J., Lichtenstein, A. K., Berenson, R. J., and Berenson, J. R. The hematopoietic stem cell antigen CD34 is not expressed on the malignant cells in multiple myeloma. Blood, 84: 3283-3290, 1994.
-
(1994)
Blood
, vol.84
, pp. 3283-3290
-
-
Vescio, R.A.1
Hong, C.H.2
Cao, J.3
Kim, A.4
Schiller, G.J.5
Lichtenstein, A.K.6
Berenson, R.J.7
Berenson, J.R.8
|